Breakthrough in HPV-Related Cancer Treatment Scientists at UT Southwestern Medical Center report that a nanoparticle-based vaccine designed to combat cancers caused by the human papillomavirus (HPV) has demonstrated dramatic effects in preclinical studies. The vaccine, built on a nanotechnology platform, target’s HPV-triggered tumors and appears to stimulate the body’s immune system to attack cancer cells…